SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination-Reference-Cited by-同舟云学术

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination

Published:2022-01-20 Issue:3 Volume:32 Page:322-324
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

Li Pengfei,Wang Yining,Lavrijsen Marla,Lamers Mart M.^ORCID,de Vries Annemarie C.,Rottier Robbert J.,Bruno Marco J.,Peppelenbosch Maikel P.^ORCID,Haagmans Bart L.^ORCID,Pan Qiuwei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41422-022-00618-w.pdf

Reference13 articles.

1. Callaway, E. Nature 600, 21 (2021).

2. Dejnirattisai, W. et al. Lancet 399, 234–236 (2022).

3. Kozlov, M. Nature https://doi.org/10.1038/d41586-021-03829-0 (2021).

4. Wang, Y. et al. Virology 564, 33–38 (2021).

5. Wahl, A. et al. Nature 591, 451–457 (2021).

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants;Antiviral Research;2024-10

2. A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system;PLOS Pathogens;2024-09-11

3. Paxlovid reduces the 28-day mortality of patients with COVID-19: a retrospective cohort study;BMC Infectious Diseases;2024-08-01

4. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

5. Assessing the inhibition efficacy of clinical drugs against the main proteases of SARS‐CoV‐2 variants and other coronaviruses;Quantitative Biology;2024-07-06